November 17, 2018
QuaCell signed strategic cooperation agreement with Sartorius
On November 16, the 13th Zhongshan Forum for Health and Development, co-sponsored by the Government of Zhongshan City and twelve first-level academic societies, was officially opened at the Hilton Hotel Zhongshan. At the MAH 2018 Biomedical CDMO/CMO Summit Forum, QuaCell Biotechnology Co., Ltd. signed a strategic cooperation agreement with Sartorius to establish the Sartorius-QuaCell QbD Research and Application Center. The two companies will collaborate in QbD application implementation, bioprocess optimization, technology & service coordination, CDMO/CMO, and other fields.
Meanwhile, Dr. Fai Poon, President of QuaCell, attended and chaired the interactive exchange session at the MAH 2018 Biomedical CDMO/CMO Summit Forum. He discussed with leaders of NMPA, academic institutions, drug R&D enterprises, and drug manufacturers, focusing on the process, scale, and production facing CMO enterprises under the MAH system. Experts attending the meeting agreed that the future development of the biomedical CDMO/CMO industry.
Congratulation!! | Quacell won the title of excellent enterprise in the 10th China Innovation and Entrepreneurship Competition (growth group)!
News | QuaCell Biotechnology announced that it had completed nearly 200 million yuan of round B financing
Dr. Poon, CEO of QuaCell Biotechnology, Co., Ltd. was honored to be elected Associate Editor of RE: GEN Open
Conclusion | Biofuture2021
BIG EVENETS. Day 2 | Biofuture 2021